Summary : JM Financial has shared several stock ideas for the coming years. From that list, five companies stand out clearly. These stocks show strong business growth, better financial health, and clear plans for expansion. According to JM Financial, some of these stocks can deliver strong returns over the medium to long term.
When brokerage firms release long lists of stock recommendations, it can be confusing for investors, especially beginners. Not every stock carries the same level of confidence or growth visibility. After carefully reviewing JM Financial’s latest report, we have selected the top five stocks that appear strongest based on earnings growth, balance sheet improvement, and long-term business potential. These companies operate in different sectors but share one common factor — improving fundamentals.
Table of Contents
1. Kalyan Jewellers: Strong Demand and Improving Financial Health
JM Financial has given a ‘Buy’ recommendation on Kalyan Jewellers with a target price of ₹750.
The brokerage is positive because the company is seeing strong customer demand, especially during the wedding season. Sales growth has been healthy across regions, and profit margins have improved.
Another important point is debt reduction. JM Financial believes the company is moving towards a much stronger balance sheet, which reduces risk and improves long-term stability.
2. Vedant Fashions: Stable Retail Business With Clear Growth
JM Financial has also kept a ‘Buy’ view on Vedant Fashions, with a target price of ₹930. The company benefits from steady demand for ethnic wear and focuses on higher-margin products. This allows it to generate consistent profits and strong cash flows.
JM Financial likes the predictability of this business. Compared to many retail companies, Vedant’s earnings are more stable and easier to forecast.
3. Sai Life Sciences: Expansion Supporting Future Growth
JM Financial has reiterated a ‘Buy’ rating on Sai Life Sciences, setting a target price of ₹1,318. The company works closely with global pharmaceutical clients and is expanding its manufacturing capacity. These new facilities are expected to support higher revenue in the coming years.
JM Financial believes strong execution and new product additions will help the company grow steadily over time.
4. Neuland Laboratories: Focus on Complex Products
JM Financial continues to recommend Neuland Laboratories as a ‘Buy’, with a target price of ₹20,836. While some parts of the business faced pressure recently, the company’s higher-value segment is growing well. This segment focuses on complex molecules, where competition is lower and margins are better.
JM Financial feels this shift can support long-term earnings growth.
5. Kaynes Technology: Order Book Gives Confidence
JM Financial has maintained a ‘Buy’ rating on Kaynes Technology, with a target price of ₹5,100. Although recent results were impacted by execution delays, the company has a strong and growing order book. It is also entering new areas within electronics manufacturing.
JM Financial believes these factors can drive growth once execution improves.
Conclusion
The five stocks highlighted by JM Financial stand out due to clear business direction, improving financial strength, and visible growth opportunities. While short-term challenges may exist, the overall outlook for these companies remains positive. For investors looking at medium- to long-term opportunities, these stocks offer a mix of growth and stability.
Disclaimer: BBK24.COM provides news and information on markets, economy, business, and personal finance for informational purposes only. We do not provide financial advice, and any action you take based on our content is at your own risk. Please consult a licensed professional before making investment decisions.